Literature DB >> 29572667

Use of Therapeutics in Pregnancy and Lactation.

Sara Eyal1,2.   

Abstract

This theme issue of Pharmaceutical Research is dedicated to drug research and therapy in pregnant and breastfeeding woman. Enthusiasm for studying drug safety and toxicity in these patients (and in their children) has risen over the past decade. Yet, the accumulation of data is slow. A combined effort of industry, regulators, academia and clinicians can promote the treatment of these populations, as discussed in detail in this issue.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29572667     DOI： 10.1007/s11095-018-2390-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  Barriers to Drug Distribution into the Perinatal and Postnatal Brain.

Authors:  Jean-François Ghersi-Egea; Elodie Saudrais; Nathalie Strazielle
Journal:  Pharm Res       Date:  2018-03-07       Impact factor: 4.200

2.  Utilization of drugs with pregnancy exposure registries during pregnancy.

Authors:  Onyekachukwu A Illoh; Sengwee Toh; Susan E Andrade; Christian Hampp; Leyla Sahin; Kate Gelperin; Lockwood Taylor; Steven T Bird
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-03-08       Impact factor: 2.890

Review 3.  Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.

Authors:  Sílvia M Illamola; Christina Bucci-Rechtweg; Maged M Costantine; Ekaterini Tsilou; Catherine M Sherwin; Anne Zajicek
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

Review 4.  The Placental Barrier: the Gate and the Fate in Drug Distribution.

Authors:  Nino Tetro; Sonia Moushaev; Miriam Rubinchik-Stern; Sara Eyal
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

Review 5.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

Review 6.  Evolving knowledge of the teratogenicity of medications in human pregnancy.

Authors:  Margaret P Adam; Janine E Polifka; J M Friedman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-07-15       Impact factor: 3.908

7.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

8.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182

9.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

Review 10.  Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.

Authors:  Asher Ornoy
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200
View more
  1 in total

1.  An exploratory survey on community pharmacists' service provision for pregnant and lactating women in Sharjah, United Arab Emirates.

Authors:  Zahraa Abdullatif Akkad; Muaed Alomar; Subish Palaian
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.